TAM
EIGR

Tocqueville Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Tocqueville Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,244
Closed -$8.38K – 558
2023
Q4 		$8.38K Sell
1,244
-459
-27% -$4.04K ﹤0.01% 516
2023
Q3 		$15.6K Hold
1,703
– – ﹤0.01% 511
2023
Q2 		$36K Hold
1,703
– – ﹤0.01% 531
2023
Q1 		$45.8K Hold
1,703
– – ﹤0.01% 523
2022
Q4 		$60.3K Sell
1,703
-683
-29% -$82.1K ﹤0.01% 568
2022
Q3 		$539K Buy
2,386
+300
+14% +$73.7K 0.01% 437
2022
Q2 		$394K Buy
2,086
+27
+1% +$5.44K 0.01% 535
2022
Q1 		$513K Buy
2,059
+90
+5% +$14.2K 0.01% 511
2021
Q4 		$307K Buy
1,969
+25
+1% +$4.83K ﹤0.01% 642
2021
Q3 		$390K Buy
1,944
+213
+12% +$50.6K 0.01% 585
2021
Q2 		$442K Sell
1,731
-33
-2% -$8.24K 0.01% 580
2021
Q1 		$468K Sell
1,764
-400
-18% -$126K 0.01% 564
2020
Q4 		$798K Sell
2,164
-175
-7% -$50.2K 0.01% 475
2020
Q3 		$571K Buy
2,339
+273
+13% +$84.9K 0.01% 468
2020
Q2 		$595K Buy
2,066
+158
+8% +$46.6K 0.01% 467
2020
Q1 		$389K Buy
1,908
+212
+13% +$67.6K 0.01% 493
2019
Q4 		$758K Buy
1,696
+490
+41% +$174K 0.01% 488
2019
Q3 		$371K Buy
1,206
+64
+6% +$20.8K 0.01% 617
2019
Q2 		$363K Buy
1,142
+350
+44% +$121K ﹤0.01% 655
2019
Q1 		$332K Sell
792
-86
-10% -$34.5K ﹤0.01% 660
2018
Q4 		$268K Buy
878
+315
+56% +$102K ﹤0.01% 648
2018
Q3 		$203K Buy
+563
New +$193K ﹤0.01% 777

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Tocqueville Asset Management's EIGR Position: Q1 2024 in Review

Tocqueville Asset Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 1,244 shares — an estimated $8.38K sold.

Tocqueville Asset Management first reported a position in EIGR in Q3 2018 and held it in 22 quarters. The position peaked at $798K in Q4 2020. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Tocqueville Asset Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Tocqueville Asset Management sold 1,244 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $8.38K.
  • Tocqueville Asset Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2018 and held it in 22 quarters.
  • Tocqueville Asset Management's Eiger BioPharmaceuticals, Inc. position peaked at $798K in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Tocqueville Asset Management's 13F filing for Q1 2024, filed 9 May 2024.